Form 4: Lifecore Biomedical Director Acquires Shares Through Restricted Stock Units

Director Humberto Calheiros Antunes acquired 24,554 shares of Lifecore Biomedical, Inc. common stock through restricted stock units.

Summary

• On August 19, 2024, Humberto Calheiros Antunes, a director of Lifecore Biomedical, Inc., acquired 24,554 shares of common stock.
• The acquisition was made through restricted stock units (RSUs).
• The RSUs convert into common stock on a 1-for-1 basis.
• The RSUs vest on the earlier of July 8, 2025, or the date of the annual meeting of stockholders first held in calendar year 2025, provided such date is no less than 50 weeks from July 8, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but it's a routine transaction via RSUs.

Positives

• A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock units is contingent upon future events, specifically the passage of time and the date of the company's annual meeting.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of shares, which is a common occurrence.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates